双氯芬酸
中文名称 | 双氯芬酸 |
---|---|
中文同义词 | 2-(2,6-二氯苯氨基)苯乙酸;2-[(2,6-二氯苯基)氨基]-苯乙酸;奥尔芬;双氯芬酸;双氯芬酸钠杂质D;双氯芬酸 10G;双氯芬酸溶液,100PPM;双氯芬酸 标准品 |
英文名称 | 1-(2,6-Dichlorophenyl)-2-indolinone |
英文同义词 | 1-(2,6-DICHLOROPHENYL)-1,3-DIHYDRO-INDOLE-2-ONE;(N-1-(2,6-DICHLOROPHENYL) -2-INDOLIN-2-ONE;2-[[2,6-Dichlorophenyl] amino] benzeneacetic acid;1-(2,6-DICHLOROPHENYL)-2-INDOLINONE /MEQUITAZINE;1-(2,6-DICHLOROPHENYL)-2-INDOLINONE/INDOLINONE;DICLOFENAC ACID/[2-(2,6-DICHLORO-PHENYLAMINO)-PHENY]-ACETIC ACID;(o-(2,6-dichloroanilino)phenyl)-acetic acid;[2-(2,6-Dichloroanilino)phenyl]-acetic acid |
CAS号 | 15307-86-5 |
分子式 | C14H11Cl2NO2 |
分子量 | 296.15 |
EINECS号 | 239-348-5 |
相关类别 | 医药原料;解热镇痛类;酶抑制剂;小分子抑制剂;其他兽药标准品;中间体;双氯芬酸钠中间体;医药化工类;原料中间体-原料药;原料药API;强效消炎镇痛;化合物:原料药:解热镇痛类;抗炎镇痛药物;Indoles and derivatives;pharmacetical;原料;主打;医药原料药;医药、农药及染料中间体;有机化工原料;API原料药-兽药原料药;化工;原料药;医用原料 |
Mol文件 | 15307-86-5.mol |
结构式 |
双氯芬酸 性质
熔点 | 156-158° |
---|---|
沸点 | 412.0±45.0 °C(Predicted) |
密度 | 1.431±0.06 g/cm3(Predicted) |
储存条件 | Sealed in dry,Room Temperature |
溶解度 | 溶于甲醇 |
形态 | 粉末晶体 |
酸度系数(pKa) | pKa 4 (Uncertain) |
颜色 | 白色到近乎白色 |
水溶解性 | 1.278mg/L(30 ºC) |
Merck | 14,3081 |
InChIKey | DCOPUUMXTXDBNB-UHFFFAOYSA-N |
CAS 数据库 | 15307-86-5(CAS DataBase Reference) |
NIST化学物质信息 | Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-(15307-86-5) |
EPA化学物质信息 | Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]- (15307-86-5) |
双氯芬酸的作用机理为抑制环氧化酶活性,从而阻断花生四烯酸向前列腺素的转化生成,因前列腺素为引起疼痛、发烧及发炎等之现象的主要因子。
双氯芬酸为白色结晶性粉末,无臭,易溶于丙酮,溶于甲,乙醇,微溶于水。双氯芬酸具有显著的抗风湿,消炎,止痛和解热作用,其抗炎作用比阿司匹林强26—50倍,能很好的解除关节疼能,消肿,改善其活动,同时具有良好的耐受性。Diclofenac acid是一种非类固醇的消炎药,具有止痛、消炎和退热活性,在治疗多种急性和慢性疼痛、炎症反应中有效。它能抑制cyclooxygenase-1 (COX-1)和cyclooxygenase-2 (COX-2),具有相近的效力。
Human COX-2 1.3 nM (IC 50 , in CHO cells) |
Human COX-1 4 nM (IC 50 , in CHO cells) |
Ovine COX-2 0.84 μM (IC 50 ) |
Ovine COX-1 5.1 μM (IC 50 ) |
Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC
50
of 7±3 nM.
Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.
Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.
Cell Viability Assay
Cell Line: | Neural stem cells (NSCs) |
Concentration: | 1, 3, 10, 30, 60 μM |
Incubation Time: | 1 day |
Result: | Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM. |
Western Blot Analysis
Cell Line: | Neural stem cells (NSCs) |
Concentration: | 10, 30 or 60 μM |
Incubation Time: | 6 hours |
Result: | The activation of caspase-3 was increased in a concentration-dependent manner. |
Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal
51
Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.
Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.
Animal Model: | Male Sprague-Dawley rats (150±200 g) |
Dosage: | 3 mg/kg |
Administration: | Oral administration, b.i.d., for 5 days |
Result: | Resulted in a significant increase in faecal 51 Cr excretion. |
Animal Model: | Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model |
Dosage: | 10 mg/kg |
Administration: | Administered via oral route just prior to induction of inflammation |
Result: | Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h). |
安全信息
危险品运输编号 | 3249 |
---|---|
RTECS号 | AG6310000 |
海关编码 | 2922.49.2600 |
危险等级 | 6.1(b) |
包装类别 | III |
毒害物质数据 | 15307-86-5(Hazardous Substances Data) |
双氯芬酸 化学药品说明书
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/11/11 | XW153078652 | 双氯芬酸 | 15307-86-5 | 5G | 49元 |
2024/11/08 | HY-15036 | 双氯芬酸 Diclofenac | 15307-86-5 | 500mg | 350元 |